Safety and efficacy of sunitinib for advanced non‐clear cell renal cell carcinoma

ConclusionSunitinib was efficacious in the treatment of advanced non‐clear cell renal cell carcinoma. Most adverse events were tolerable.

Source: Asia-Pacific Journal of Clinical Oncology - October 15, 2015 Category: Cancer & Oncology Authors: Hong‐Zhe Shi, Jun Tian, Chang‐Ling Li Tags: Original Article Source Type: research